European Partnership on Rare Diseases (ERDERA) (Phase 2) vs Towards a European production of stable isotopes for novel nuclear medicine therapies (SAMIRA/ERVI)
Side-by-side comparison of two grants.
| Attribute | European Partnership on Rare Diseases (ERDERA) (Phase 2) | Towards a European production of stable isotopes for novel nuclear medicine therapies (SAMIRA/ERVI) |
|---|---|---|
| Type | Grant | Grant |
| Funding amount | $104.3M | $2.3M |
| Deadline | Closes 2026-09-15 | Closes 2026-09-15 |
| Region | EU | EU |
| Sector | Health | Health |
| Funder | European Commission (HORIZON) | European Commission (HORIZON) |
| Who it's for | researchers | — |